1-3 of 3
Congxiao Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter Randomized Controlled Trial of Low-Dose Ruxolitinib for Gvhd Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation

Hengwei Wu, Jimin Shi, Yi Luo, Jian Yu, Huarui Fu, Lizhen Liu, Xiaoyu Lai, Luxin Yang, Yishan Ye, Congxiao Zhang, Weijie Cao, Junjie Cao, Xiaojun Xu, Xiaoxia Hu, Ying Lu, He Huang, Yanmin Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 1044.
https://doi.org/10.1182/blood-2024-206823
Published: 2024
Journal Articles

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Yanmin Zhao, Yi Luo, Jimin Shi, Shunqing Wang, Caixia Wang, Erlie Jiang, Chen Liang, Xiaoyu Zhu, Xuejun Zhang, Fankai Meng, Hua Jin, Yeqian Zhao, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Yishan Ye, Congxiao Zhang, Tao Wang, Lifan Tu, Xunqiang Wang, He Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 97.
https://doi.org/10.1182/blood-2024-204703
Published: 2024
Journal Articles

Prognostic Effect and Clinical Application of Early Measurable Residual Disease (MRD) By Flow Cytometry on De Novo Acute Myeloid Leukemia (AML)

Congxiao Zhang, Runxia Gu, Chunlin Zhou, Yan Li, Yuntao Liu, Shuning Wei, Dong Lin, Benfa Gong, Kaiqi Liu, Qiuyun Fang, Xiaoyuan Gong, Shaowei Qiu, Bingcheng Liu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 2030–2032.
https://doi.org/10.1182/blood-2022-162459
Published: 2022